Literature DB >> 9884121

Ethopharmacology of imipramine in the forced-swimming test: gender differences.

H M Barros1, M Ferigolo.   

Abstract

Most of the pre-clinical tests used to assay the efficacy of prospective new agents are done with male experimental animals. In this case, a large part of the population is disregarded as is the interaction of the new agent's effects with female hormonal fluctuations. The present study reviews the technical procedures characteristic for the forced-swimming test and the behavioral outcome induced by the testing procedure in males. It also compares the anti-immobility effects of the classic antidepressant imipramine (IMI) in male and female rats using a detailed behavioral scoring. Female rats had vaginal smears done before the beginning of the behavioral testing and were administered with three doses 24 h, 5 h and 1 h before the retest, as were male rats. Tests were videotape-recorded for analysis of the frequency and duration of the behaviors during forced-swimming. Male rats spend around 50% of the time immobile during the retest. There was a significant, dose-dependent decrease in immobility duration and a decrease in head-shakes of male rats treated with IMI. Both active behaviors of climbing and swimming were equally enhanced by the tricyclic antidepressant, climbing behavior comprising 75% of the mobile behaviors. Females showed much lower immobility duration and head-shake frequency during the forced-swimming than males and spent longer periods in mobile behaviors. Imipramine only decreases immobility frequency and head-shakes of females, and increases the escape-type behavior of climbing, decreasing swimming in the middle of the tank. This effect is more noticeable during estrus and proestrus. These results demonstrate the main behavioral differences between males and females in the forced-swimming test. It also elucidates that the effects of imipramine are measurable in males using the duration of the behaviors, while the frequencies of behaviors are modified in females treated with imipramine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884121     DOI: 10.1016/s0149-7634(98)00029-3

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  29 in total

1.  Sex-related differences: do they matter?

Authors:  P Hrdina
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Formation of behavioral pathology in female C57BL/6J mice exposed to prolonged negative psychoemotional conditions.

Authors:  D F Avgustinovich; I L Kovalenko
Journal:  Neurosci Behav Physiol       Date:  2005-11

Review 3.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

4.  Developmental exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory factor (LIF) and corticotropin-releasing hormone (CRH) gene expression in the mouse.

Authors:  Robert N Pechnick; Anastasia Kariagina; Evelyn Hartvig; Catherine J Bresee; Russell E Poland; Vera M Chesnokova
Journal:  Psychopharmacology (Berl)       Date:  2006-01-14       Impact factor: 4.530

5.  Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.

Authors:  Cheryl A Frye
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

6.  Progesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2011-06-06       Impact factor: 3.533

7.  Gender-related characteristics of responding to prolonged psychoemotional stress in mice.

Authors:  D F Avgustinovich; I L Kovalenko
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

Review 8.  Reconceptualizing sex, brain and psychopathology: interaction, interaction, interaction.

Authors:  D Joel; R Yankelevitch-Yahav
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats.

Authors:  Elizabeth T Nguyen; Joshua Streicher; Sarah Berman; Jody L Caldwell; Valentina Ghisays; Christina M Estrada; Aynara C Wulsin; Matia B Solomon
Journal:  Physiol Behav       Date:  2017-01-14

10.  Effect of chronic treatment with ladostigil (TV-3326) on anxiogenic and depressive-like behaviour and on activity of the hypothalamic-pituitary-adrenal axis in male and female prenatally stressed rats.

Authors:  Tatyana Poltyrev; Elena Gorodetsky; Corina Bejar; Donna Schorer-Apelbaum; Marta Weinstock
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.